CXCR3 and neoplasm: Accordingly in order to determine whether TDLN/Tumor derived T cells in NLGP-treated animals are expressing more chemotactic components over PBS mice, we assessed CD8+ T cells for their expression of CXCR3 and corresponding ligands on day 21 sarcoma mice.